Wednesday, December 17, 2025
Wednesday, December 17, 2025

A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future risk of developing serious liver complications compared with patients who received medical therapy alone.

Researchers have developed a new chemical tool that could help lower the cost of prescription medications. The tool, called AshPhos, is a ligand, or molecule, that makes it easier to create special carbon-nitrogen bonds. These bonds are the backbone of more than half of all medicines on the market today.

More Articles …

  1. Skin cancer: New treatment option successfully tested
  2. What drives mood swings in bipolar disorder? Study points to a second brain clock
  3. Farm worker contracts human case of bird flu
  4. Why does it hurt when you get a scrape? A neuroscientist explains the science of pain
  5. Pharmacists in warning over weight-loss jab sales
  6. Combination of dual-targeted therapies and chemotherapy shows high response rates in BRAF-mutated metastatic colorectal cancer
Page 686 of 1933